Literature DB >> 23178106

Association between the duration of untreated psychosis and short- and long-term outcome in schizophrenia within the Northern Finland 1966 Birth Cohort.

Matti Penttilä1, Jouko Miettunen, Hannu Koponen, Merja Kyllönen, Juha Veijola, Matti Isohanni, Erika Jääskeläinen.   

Abstract

BACKGROUND: Long duration of untreated psychosis (DUP) may relate to poor outcome in schizophrenia. However, the associations between DUP and outcomes, particularly in later course of illness, remain unclear. Our aim was to explore the associations between DUP and short- and long-term outcomes in schizophrenia.
METHODS: Data was collected for subjects with schizophrenia (n=89) in the population-based Northern Finland 1966 Birth Cohort. DUP was obtained from medical records, and its associations with short- (under 2years) and long-term clinical and social outcomes were assessed extending to 20years after the onset of the illness.
RESULTS: Longer DUP predicted longer length of first hospitalisation and increased the risk of rehospitalisation during the first two years. Longer DUP associated with decreased probability of disability pension, smaller amount of time spent in hospital, and higher proportion of time at work during the first 10years of the follow-up.
CONCLUSIONS: Regarding early outcome, long DUP may be a modest marker and proxy measure of a more severe clinical phenotype. The divergent results of earlier studies and the association between long DUP and better long-term outcome in our study, indicate that the length of DUP does not necessarily predict poor outcome in long-term follow-up. This may also be due to methodical difficulties, e.g. insufficient power and residual confounding linked to long follow-up studies.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23178106     DOI: 10.1016/j.schres.2012.10.029

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  10 in total

1.  Youth Mental Health Services: Promoting Wellness or Treating Mental Illness?

Authors:  Ashok Malla; Alyssa Frampton; Bilal Issaoui Mansouri
Journal:  Can J Psychiatry       Date:  2020-04-22       Impact factor: 4.356

2.  The efficacy of targeted health agents education to reduce the duration of untreated psychosis in a rural population.

Authors:  Eduardo Padilla; Juan Molina; Danielle Kamis; Maria Calvo; Lee Stratton; Sergio Strejilevich; Gabriela Gonzalez Aleman; Gonzalo Guerrero; Mercedes Bourdieu; Horacio A Conesa; Javier I Escobar; Gabriel A de Erausquin
Journal:  Schizophr Res       Date:  2014-11-28       Impact factor: 4.939

Review 3.  What does schizophrenia teach us about antipsychotics?

Authors:  Gary Remington; Ofer Agid; George Foussias; Gagan Fervaha; Hiroyoshi Takeuchi; Jimmy Lee; Margaret Hahn
Journal:  Can J Psychiatry       Date:  2015-03       Impact factor: 4.356

4.  Individual risk alleles of susceptibility to schizophrenia are associated with poor clinical and social outcomes.

Authors:  Shinji Sakamoto; Manabu Takaki; Yuko Okahisa; Yutaka Mizuki; Masatoshi Inagaki; Hiroshi Ujike; Toshiharu Mitsuhashi; Soshi Takao; Masashi Ikeda; Yosuke Uchitomi; Nakao Iwata; Norihito Yamada
Journal:  J Hum Genet       Date:  2015-12-17       Impact factor: 3.172

5.  Early-life factors associated with increased risk of disability pension in the national real-world schizophrenia FACE-SZ cohort study.

Authors:  G Fond; J Dubreucq; P L Sunhary de Verville; O Godin; C Andrieu-Haller; F Berna; B Aouizerate; D Capdevielle; I Chereau; J Clauss-Kobayashi; N Coulon; J M Dorey; C Dubertret; J Mallet; D Misdrahi; C Passerieux; R Rey; B Pignon; F Schürhoff; M Urbach; P M Llorca; C Lançon; L Boyer
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2022-03-25       Impact factor: 5.760

Review 6.  Twenty Years of Schizophrenia Research in the Northern Finland Birth Cohort 1966: A Systematic Review.

Authors:  Erika Jääskeläinen; Marianne Haapea; Nina Rautio; Pauliina Juola; Matti Penttilä; Tanja Nordström; Ina Rissanen; Anja Husa; Emmi Keskinen; Riikka Marttila; Svetlana Filatova; Tiina-Mari Paaso; Jenni Koivukangas; Kristiina Moilanen; Matti Isohanni; Jouko Miettunen
Journal:  Schizophr Res Treatment       Date:  2015-05-18

7.  Services for people at high risk improve outcomes in patients with first episode psychosis.

Authors:  P Fusar-Poli; C M Díaz-Caneja; R Patel; L Valmaggia; M Byrne; P Garety; H Shetty; M Broadbent; R Stewart; P McGuire
Journal:  Acta Psychiatr Scand       Date:  2015-09-11       Impact factor: 6.392

8.  Effectiveness and safety of blonanserin for improving social and cognitive functions in patients with first-episode schizophrenia: a study protocol for a prospective, multicentre, single-arm clinical trial.

Authors:  Chengcheng Pu; Lei Lei; Fude Yang; Hong Deng; Jianhua Sheng; Zhening Liu; Shaohua Hu; Lina Wang; Bin Wu; Qijing Bo; Yoshifumi Inoue; Xin Yu
Journal:  BMJ Open       Date:  2022-04-20       Impact factor: 2.692

9.  Poor premorbid school performance, but not severity of illness, predicts cognitive decline in schizophrenia in midlife.

Authors:  Irina Rannikko; Graham K Murray; Pauliina Juola; Henri Salo; Marianne Haapea; Jouko Miettunen; Juha Veijola; Jennifer H Barnett; Anja P Husa; Peter B Jones; Marjo-Riitta Järvelin; Matti Isohanni; Erika Jääskeläinen
Journal:  Schizophr Res Cogn       Date:  2015-09-09

10.  Factors that influence delaying initial psychiatric treatment in rural Cambodia: A pilot study.

Authors:  Akihiro Nishio; Ryo Horita; Toshiyuki Marutani; Mayumi Yamamoto
Journal:  PLoS One       Date:  2018-11-01       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.